Effects of a Quick-Release Form of Bromocriptine (Ergoset) on Fasting and Postprandial Plasma Glucose, Insulin, Lipid, and Lipoprotein Concentrations in Obese Nondiabetic Hyperinsulinemic Women - Concepedia

Concepedia

Publication | Closed Access

Effects of a Quick-Release Form of Bromocriptine (Ergoset) on Fasting and Postprandial Plasma Glucose, Insulin, Lipid, and Lipoprotein Concentrations in Obese Nondiabetic Hyperinsulinemic Women

104

Citations

0

References

1997

Year

Vinaya Kamath, C. N. O. Jones, Jeannie C Yip, B. B. Varasteh, Anthony H. Cincotta, Gerald M. Reaven, Yii‐Der I. Chen

Abstract

The fact that significant metabolic improvement was seen in the obese nondiabetic hyperinsulinemic women studied suggests that Ergoset could be of therapeutic benefit in clinical conditions of hyperglycemia and/or dyslipidemia.